Capital Fund Management (CFM)’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-304,105
| Closed | -$1.45M | – | 768 |
|
|
2023
Q2 | $1.45M | Buy |
304,105
+232,494
| +325% | +$1.11M | 0.01% | 460 |
|
|
2023
Q1 | $408K | Sell |
71,611
-37,935
| -35% | -$216K | ﹤0.01% | 514 |
|
|
2022
Q4 | $1.11M | Buy |
+109,546
| New | +$1.11M | 0.01% | 421 |
|
|
2020
Q4 | – | Sell |
-24,077
| Closed | -$962K | – | 670 |
|
|
2020
Q3 | $962K | Buy |
24,077
+3,967
| +20% | +$159K | 0.01% | 390 |
|
|
2020
Q2 | $690K | Buy |
+20,110
| New | +$690K | 0.01% | 392 |
|
|
2020
Q1 | – | Sell |
-20,001
| Closed | -$391K | – | 974 |
|
|
2019
Q4 | $391K | Buy |
+20,001
| New | +$391K | ﹤0.01% | 709 |
|